{"meta":{"query_hash":"7c52c15b5d02","filters":{"venue":"Cancer Drug Resistance"},"cohort_total":12,"direct_labels_cover":0,"predictions_cover":12,"exported":12,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7c52c15b5d02","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Drug+Resistance"},"results":[{"id":"W2898571509","doi":"10.20517/cdr.2018.18","title":"Meeting Abstracts of the BACR conference: response and resistance in cancer therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Neuroblastoma; Anaplastic lymphoma kinase; Cancer research; Medicine; Targeted therapy; Oncogene; N-Myc; Cancer; Oncology; Internal medicine; Biology; Lung cancer; Cell cycle; Genetics; Cell culture","score_opus":0.030755088127442792,"score_gpt":0.33808337746355077,"score_spread":0.307328289336108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898571509","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025486574,0.19406827,0.0021698105,0.33781907,0.39229283,0.0007842081,0.002175743,0.00037304204,0.06776848],"genre_scores_gemma":[0.026634883,0.1650857,0.003721456,0.06542567,0.49270645,0.0014230463,0.0035060144,0.0005084821,0.24098828],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565697,0.0014712946,0.00047877058,0.00045047744,0.00149642,0.00044601734],"domain_scores_gemma":[0.9904004,0.0016020999,0.00089203287,0.00020775967,0.0040938817,0.0028038921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00858484,0.0019816633,0.0018612852,0.0019550314,0.0014996036,0.004977183,0.002091572,0.00812099,0.06663832],"category_scores_gemma":[0.014064387,0.00049905863,0.0017522491,0.0013267164,0.0008660606,0.0023568985,0.0032592071,0.006794873,0.026696036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002480417,0.00004892781,0.00022911838,0.0004418974,0.00002763707,0.00006243571,0.00003009202,0.0000893711,0.0002975269,0.0005043581,0.9543256,0.043694843],"study_design_scores_gemma":[0.00010486326,0.00018907529,0.0023323535,0.0011653935,0.00006816994,0.00026510615,0.000099324774,0.00022196949,0.00027486848,0.0012896501,0.9939511,0.00003827712],"about_ca_topic_score_codex":0.002104919,"about_ca_topic_score_gemma":0.0052809254,"teacher_disagreement_score":0.06663832,"about_ca_system_score_codex":0.003935362,"about_ca_system_score_gemma":0.004706739,"threshold_uncertainty_score":0.22292739},"labels":[],"label_agreement":null},{"id":"W2915554719","doi":"10.20517/cdr.2018.21","title":"Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET","year":2018,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Nuclear medicine; Radiation therapy; Voxel; Tumor hypoxia; Glioblastoma; Misonidazole; Hypoxia (environmental); Pet imaging; Positron emission tomography; Medicine; Chemistry; Radiology; Cancer research; Oxygen","score_opus":0.007193521029328238,"score_gpt":0.30235791045602745,"score_spread":0.2951643894266992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915554719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801587,0.0053537046,0.011106826,0.00022509947,0.000016645023,0.00003629081,0.00027767275,0.00009605857,0.0027291381],"genre_scores_gemma":[0.9918594,0.0018382632,0.004589406,0.000048828304,0.000012190347,0.00004237954,0.00021596454,0.000029593304,0.0013639469],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999573,0.000011055123,0.0000019238298,0.000008483842,0.000005914058,0.00001529994],"domain_scores_gemma":[0.9999647,0.000012277595,0.000006637157,0.0000036576796,0.000007655124,0.000005015166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023104472,0.00017668161,0.00022146452,0.00036141084,0.00019086685,0.00030371232,0.0002561136,0.0002973007,0.0008976781],"category_scores_gemma":[0.00023453332,0.00017301676,0.00011825588,0.00024108977,0.00018783234,0.0002959275,0.00014818,0.00015617583,0.00017628314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009192401,0.000049577015,0.003228417,0.00014764757,0.000017463019,0.00043199447,0.00013657878,0.0009927845,0.97791094,0.00028526553,0.00026640994,0.015613614],"study_design_scores_gemma":[0.000104370985,0.0015724606,0.06272715,0.000054749704,0.00020326313,0.0041921204,0.00036356915,0.015757866,0.9063639,0.00050051603,0.008120805,0.000039251932],"about_ca_topic_score_codex":0.0074081174,"about_ca_topic_score_gemma":0.00543139,"teacher_disagreement_score":0.0074081174,"about_ca_system_score_codex":0.00031061523,"about_ca_system_score_gemma":0.00028847056,"threshold_uncertainty_score":0.014729977},"labels":[],"label_agreement":null},{"id":"W2941758788","doi":"10.20517/cdr.2018.24","title":"Pharmacogenetics of asparaginase in acute lymphoblastic leukemia","year":2019,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fondation Charles-Bruneau; Cancer Research Society","keywords":"Pharmacogenetics; Asparaginase; Medicine; Lymphoblastic Leukemia; Acute pancreatitis; Leukemia; Pharmacology; Intensive care medicine; Oncology; Internal medicine; Genotype; Biology; Genetics; Gene","score_opus":0.04136947507326984,"score_gpt":0.37842092036967073,"score_spread":0.3370514452964009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941758788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106299114,0.9992167,0.00004885249,0.00014153055,0.00005408814,0.0000027071756,0.0000201836,0.0000023472396,0.00040730237],"genre_scores_gemma":[0.00073507195,0.99888605,0.000088842404,0.000090748494,0.000044366694,0.000003479724,0.000025320951,6.211925e-7,0.00012554863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997254,0.000074542375,0.00006367658,0.000043431777,0.0000758676,0.00001710643],"domain_scores_gemma":[0.9993525,0.0004241133,0.00009974452,0.000013114101,0.0000918095,0.000018654333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006007731,0.00044380844,0.0011282422,0.0021682458,0.00015687567,0.00078707695,0.0005181958,0.00063743966,0.002581717],"category_scores_gemma":[0.0015335476,0.00015490451,0.0006783559,0.002698385,0.00024928813,0.0006427906,0.00044933215,0.00084617944,0.0006585308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100765756,0.000041000367,0.0004923031,0.05261968,0.00032095815,0.00018938862,0.00007553617,0.00032138388,0.00077532115,0.002628632,0.014322973,0.928112],"study_design_scores_gemma":[0.00003541823,0.00015588838,0.0033274018,0.026245702,0.0009844513,0.0026233613,0.00010876808,0.000138551,0.00058892235,0.0025532278,0.9632121,0.000026325313],"about_ca_topic_score_codex":0.0013011631,"about_ca_topic_score_gemma":0.0019735508,"teacher_disagreement_score":0.002581717,"about_ca_system_score_codex":0.0004841056,"about_ca_system_score_gemma":0.0011801398,"threshold_uncertainty_score":0.008636713},"labels":[],"label_agreement":null},{"id":"W3010768407","doi":"10.20517/cdr.2019.77","title":"Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells","year":2020,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Microfluidic and Capillary Electrophoresis Applications","field":"Engineering","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University; Griffith University","keywords":"Paclitaxel; Multiple drug resistance; Daunorubicin; Drug resistance; Breast cancer; Cancer cell; Efflux; Drug; Cancer; Single-cell analysis; Chemotherapy; Pharmacology; Cancer research; Cell; Liquid biopsy; Intracellular; Medicine; Triple-negative breast cancer; Chemistry; Biology; Internal medicine; Cell biology; Biochemistry","score_opus":0.01725757633327239,"score_gpt":0.21149846755830162,"score_spread":0.19424089122502924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010768407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8648175,0.0022480665,0.12681319,0.0004630559,0.00023834917,0.0001243016,0.001091763,0.0011135042,0.0030902398],"genre_scores_gemma":[0.92387015,0.0009199816,0.072636545,0.00015846899,0.000029217219,0.00019978175,0.00026040926,0.00003441645,0.0018910043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997893,0.000023744853,0.000013149068,0.000067492656,0.0000753261,0.000031097843],"domain_scores_gemma":[0.99976593,0.00011691433,0.000029654428,0.00002633498,0.000038940107,0.000022181415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028821352,0.00026851738,0.00036488543,0.0002067335,0.00017226134,0.00030942025,0.00028954682,0.0003855239,0.000603502],"category_scores_gemma":[0.0003095495,0.00013465967,0.00015523736,0.00016244882,0.00022949577,0.00018742212,0.00016762302,0.00033052117,0.00022062592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015712427,0.000009563957,0.00009193652,0.000014805037,0.0000025845854,0.0000137820825,0.000010856313,0.00007757543,0.9978313,0.000112882255,0.000073574745,0.0017453824],"study_design_scores_gemma":[0.0000024191627,0.000045009856,0.0004928347,0.0000014239303,0.000004478863,0.00003972579,0.0000053658264,0.0022456637,0.99637103,0.000031636875,0.00075527537,0.0000051322604],"about_ca_topic_score_codex":0.00057651283,"about_ca_topic_score_gemma":0.0010959724,"teacher_disagreement_score":0.000603502,"about_ca_system_score_codex":0.00036113153,"about_ca_system_score_gemma":0.00029293654,"threshold_uncertainty_score":0.0026202202},"labels":[],"label_agreement":null},{"id":"W3038775292","doi":"10.20517/cdr.2020.20","title":"Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance","year":2020,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nanocarriers; Nanomedicine; Nanotechnology; Cancer therapy; Cancer; Multiple drug resistance; Broad spectrum; Drug; Drug resistance; Drug delivery; Medicine; Materials science; Pharmacology; Nanoparticle; Chemistry; Biology; Combinatorial chemistry; Internal medicine","score_opus":0.06664426291510613,"score_gpt":0.2876834602369446,"score_spread":0.22103919732183847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038775292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002095263,0.9914711,0.0017280615,0.0003218247,0.00021657615,0.000025101179,0.00003883789,0.000039019655,0.004064203],"genre_scores_gemma":[0.0075838543,0.98803467,0.001386889,0.00029922853,0.00008350482,0.000032474953,0.000064482614,0.0000067811643,0.0025081495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988484,0.000017511198,0.00000887299,0.000024427443,0.000045401368,0.000019019688],"domain_scores_gemma":[0.99994016,0.00002432495,0.000012097445,0.000002637877,0.00001475736,0.000006086099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028921076,0.000572923,0.000665847,0.0014634926,0.0002032021,0.00055553525,0.00041980753,0.000733719,0.0023787087],"category_scores_gemma":[0.00021370673,0.00024584905,0.0005055243,0.0009510639,0.00024337831,0.000707191,0.000502049,0.0009816983,0.0012023859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008439179,0.00019839386,0.00021971781,0.024637343,0.00011186623,0.00044644362,0.00017040622,0.001662829,0.06690018,0.012047951,0.017054996,0.87646544],"study_design_scores_gemma":[0.000019062238,0.0002902474,0.00059832935,0.0018443532,0.000119514865,0.0012877409,0.00007094331,0.00077073445,0.020551959,0.0022181906,0.97219706,0.000031905744],"about_ca_topic_score_codex":0.0006805721,"about_ca_topic_score_gemma":0.0011919774,"teacher_disagreement_score":0.0023787087,"about_ca_system_score_codex":0.00038478937,"about_ca_system_score_gemma":0.00046229304,"threshold_uncertainty_score":0.007957578},"labels":[],"label_agreement":null},{"id":"W4285112075","doi":"10.20517/cdr.2022.36","title":"Base excision repair accessory factors in senescence avoidance and resistance to treatments","year":2022,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"DNA damage; Senescence; DNA repair; Biology; Base excision repair; Oxidative stress; Cell biology; Cancer cell; Cancer research; Reactive oxygen species; Cancer; Genetics; DNA; Biochemistry","score_opus":0.04487092346915068,"score_gpt":0.3636242295136351,"score_spread":0.31875330604448443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285112075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004301908,0.990776,0.0011355396,0.0003641058,0.0003431311,0.0000134444945,0.000050083723,0.000033148684,0.0029827347],"genre_scores_gemma":[0.03971256,0.95166194,0.0017665131,0.0005463165,0.0004608253,0.000037858823,0.00022045558,0.000014349663,0.0055791065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998097,0.00003803791,0.000030739066,0.000036560716,0.000058332942,0.000026704423],"domain_scores_gemma":[0.99983525,0.00005456499,0.000036160687,0.000005856071,0.000053781525,0.000014402396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003245296,0.0004115873,0.0005844332,0.00088992395,0.00016144033,0.0007911006,0.00036406645,0.0007293647,0.001414752],"category_scores_gemma":[0.00045702397,0.00014503722,0.00036597953,0.00054483453,0.00028055315,0.0006546052,0.00031368312,0.000940977,0.00064118963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003591051,0.00013374974,0.0012515909,0.023044262,0.00023213589,0.0010816009,0.00054058875,0.0010701045,0.115484424,0.019707141,0.019871254,0.8172241],"study_design_scores_gemma":[0.000022274206,0.0002913426,0.0033321737,0.0013829902,0.00015914095,0.002520233,0.00011429865,0.0002666584,0.02295222,0.0029456962,0.96598023,0.00003266237],"about_ca_topic_score_codex":0.00035380726,"about_ca_topic_score_gemma":0.0005058892,"teacher_disagreement_score":0.001414752,"about_ca_system_score_codex":0.000444578,"about_ca_system_score_gemma":0.0003824306,"threshold_uncertainty_score":0.0047327876},"labels":[],"label_agreement":null},{"id":"W4285164532","doi":"10.20517/cdr.2022.37","title":"Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer","year":2022,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Liquid biopsy; Breast cancer; Palbociclib; Acquired resistance; Medicine; Oncology; Cancer; Internal medicine; Aromatase inhibitor; Estrogen receptor; Discovery and development of mTOR inhibitors; Circulating tumor cell; Cancer research; Biomarker; Metastatic breast cancer; Biology; Tamoxifen; Signal transduction; PI3K/AKT/mTOR pathway; Metastasis","score_opus":0.013945723214104208,"score_gpt":0.2892108640727782,"score_spread":0.275265140858674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285164532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089797766,0.9988457,0.00019728763,0.00020238054,0.00016330674,0.000005157087,0.0000159643,0.000006182352,0.0004742403],"genre_scores_gemma":[0.00074900204,0.99804926,0.00032034234,0.0002353283,0.00015264536,0.000009373277,0.000041312687,0.000002131544,0.00044057413],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996178,0.000098819684,0.000044178927,0.000071234266,0.00014337403,0.000024585994],"domain_scores_gemma":[0.99927396,0.00043547404,0.00007464947,0.000015692194,0.00016876073,0.000031425796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013232033,0.00095670816,0.0017000337,0.0025855764,0.00015433173,0.0009474656,0.0010601958,0.0011888671,0.0018296429],"category_scores_gemma":[0.0014227458,0.00038164284,0.00066782185,0.0015562848,0.0005294427,0.0011823829,0.00062659534,0.0018925536,0.0015725693],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008322105,0.00004353439,0.000343003,0.007942872,0.00013067125,0.00013310308,0.000025560765,0.0002419942,0.001097842,0.0014929596,0.015052037,0.9734133],"study_design_scores_gemma":[0.000051477004,0.00025102356,0.0030566072,0.0074936682,0.00041013636,0.0034517355,0.0000919805,0.0004171103,0.0017414355,0.0030928822,0.979887,0.0000549127],"about_ca_topic_score_codex":0.0010435272,"about_ca_topic_score_gemma":0.0019780272,"teacher_disagreement_score":0.0025855764,"about_ca_system_score_codex":0.00067414815,"about_ca_system_score_gemma":0.00082017976,"threshold_uncertainty_score":0.0069978833},"labels":[],"label_agreement":null},{"id":"W4312464844","doi":"10.20517/cdr.2022.40","title":"Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach","year":2022,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Cancer Centre","funders":"National Cancer Institute","keywords":"Breast cancer; Profiling (computer programming); Medicine; Cancer; Tumor heterogeneity; Broad spectrum; Precision medicine; Acquired resistance; Computational biology; Bioinformatics; Biology; Internal medicine; Pathology; Computer science","score_opus":0.03615936449857441,"score_gpt":0.3235189367208889,"score_spread":0.28735957222231445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312464844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5142249,0.004046643,0.46671742,0.004115505,0.00009930079,0.00016962938,0.0007595851,0.0007164612,0.009150531],"genre_scores_gemma":[0.9387692,0.0010593947,0.057587363,0.00039544463,0.000047996353,0.00011965418,0.00033390615,0.000071434675,0.0016155449],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996977,0.0001394151,0.000013854503,0.000058899583,0.000055590204,0.000034661352],"domain_scores_gemma":[0.9991716,0.00057949475,0.00011792692,0.000048043108,0.000039785133,0.000043120053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011708484,0.0003793672,0.0009880993,0.0008792095,0.00031165968,0.0010353989,0.0007136073,0.0007465595,0.0013860778],"category_scores_gemma":[0.0023821737,0.00039025323,0.0009175167,0.0006108694,0.0005011093,0.00086533726,0.0008901873,0.0007019593,0.00013562213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010034512,0.00007514627,0.0034665533,0.00011248424,0.00012297484,0.00012885366,0.000049794435,0.9592832,0.0030102013,0.009933779,0.0008596756,0.022857105],"study_design_scores_gemma":[0.000023895547,0.00003744627,0.00048103218,0.000008302863,0.000025526346,0.00005165333,0.000026988517,0.9855172,0.00045950254,0.012460218,0.000901165,0.000007045392],"about_ca_topic_score_codex":0.0028303768,"about_ca_topic_score_gemma":0.004023653,"teacher_disagreement_score":0.0028303768,"about_ca_system_score_codex":0.00085846696,"about_ca_system_score_gemma":0.0009287551,"threshold_uncertainty_score":0.0062286854},"labels":[],"label_agreement":null},{"id":"W4312557334","doi":"10.20517/cdr.2022.63","title":"Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review","year":2022,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"Fonds de Recherche du Québec - Santé; Fondation du cancer du sein du Québec; Université Laval","keywords":"Breast cancer; Epigenetics; Oncology; DNA methylation; Cancer; Genetic association; Medicine; Genome-wide association study; Population; Internal medicine; Bioinformatics; Biology; Gene; Genetics; Genotype; Single-nucleotide polymorphism; Gene expression","score_opus":0.011987418497592932,"score_gpt":0.30190014810543225,"score_spread":0.2899127296078393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312557334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030339079,0.9961511,0.000059347803,0.0001659369,0.000039421364,0.000023429782,0.0003933694,0.000002409907,0.00013111712],"genre_scores_gemma":[0.027782654,0.9708713,0.00032164837,0.00040579776,0.00007786288,0.00007845232,0.00038698106,0.0000032531445,0.0000720296],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974317,0.0006098479,0.0011590857,0.00034355753,0.0003777728,0.00007802982],"domain_scores_gemma":[0.97922224,0.016468383,0.0028423406,0.0003013137,0.0010499158,0.00011591701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003135551,0.00056364905,0.0034820605,0.0057584364,0.00022004945,0.0012637579,0.00077469565,0.00087720115,0.0016658042],"category_scores_gemma":[0.0135611165,0.00039178377,0.003946629,0.008216607,0.0004375836,0.0010106316,0.0006171145,0.00048906606,0.00013582532],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004681148,0.000030604828,0.01958705,0.8459539,0.02267762,0.0003657895,0.00034848004,0.00016735561,0.0009392603,0.00029475256,0.0022684454,0.1068986],"study_design_scores_gemma":[0.00029425396,0.00045652073,0.132894,0.5690194,0.23763767,0.0026979137,0.00084210484,0.00021076646,0.0010183,0.00076269393,0.05405629,0.00011018729],"about_ca_topic_score_codex":0.0034437578,"about_ca_topic_score_gemma":0.010928532,"teacher_disagreement_score":0.0057584364,"about_ca_system_score_codex":0.00091467425,"about_ca_system_score_gemma":0.0028118494,"threshold_uncertainty_score":0.016582549},"labels":[],"label_agreement":null},{"id":"W4382278483","doi":"10.20517/cdr.2023.02","title":"Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors","year":2023,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Context (archaeology); Medicine; Immune checkpoint; Clear cell renal cell carcinoma; Renal cell carcinoma; Disease; Narrative review; Immune system; Immunotherapy; Life expectancy; Oncology; Intensive care medicine; Cancer research; Immunology; Internal medicine; Biology","score_opus":0.0701794746677465,"score_gpt":0.39633057910282576,"score_spread":0.3261511044350793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382278483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004728948,0.99938047,0.00003059756,0.00013338593,0.00008279806,0.0000029255386,0.000011207433,0.0000021208818,0.0003091591],"genre_scores_gemma":[0.00029654443,0.99925023,0.00006471442,0.00012522112,0.00008416671,0.0000036235451,0.000015435393,5.381006e-7,0.00015947105],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99981993,0.00004088939,0.000038056736,0.000029254119,0.0000574336,0.000014428406],"domain_scores_gemma":[0.99957484,0.00024222778,0.00007547985,0.0000074763966,0.00007828561,0.000021771868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056417927,0.0006965406,0.001364308,0.002204446,0.00026053446,0.00097277743,0.0007476502,0.00079361943,0.003307348],"category_scores_gemma":[0.0009872575,0.00024067386,0.000692886,0.0023808437,0.0002922637,0.0010956633,0.00061469217,0.0012870689,0.0009040104],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009820816,0.00005774853,0.00014028844,0.07721401,0.00022247391,0.00023313508,0.00011559606,0.00047727034,0.0008049349,0.0038252021,0.040048733,0.87676245],"study_design_scores_gemma":[0.000027100676,0.0001454477,0.0007730859,0.02766257,0.00046285996,0.0017725029,0.00010361403,0.00012699488,0.00023318117,0.0019159013,0.96675307,0.00002370662],"about_ca_topic_score_codex":0.0011591723,"about_ca_topic_score_gemma":0.002461233,"teacher_disagreement_score":0.003307348,"about_ca_system_score_codex":0.0005654775,"about_ca_system_score_gemma":0.0011548272,"threshold_uncertainty_score":0.011064172},"labels":[],"label_agreement":null},{"id":"W4407249734","doi":"10.20517/cdr.2024.164","title":"Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance","year":2025,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immune system; Tumor microenvironment; Cancer cell; Biology; Cancer research; Cancer; Metabolic pathway; Immunology; Metabolism; Biochemistry","score_opus":0.010493319862574207,"score_gpt":0.2897326410551759,"score_spread":0.27923932119260164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407249734","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48393676,0.41654068,0.055954497,0.021559536,0.0013338773,0.00010149548,0.001400772,0.0008935232,0.018278861],"genre_scores_gemma":[0.8798924,0.099897504,0.012381336,0.0024476289,0.0006716661,0.00008010532,0.00046604528,0.00010314419,0.0040602293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998667,0.000030143881,0.0000059781755,0.000034103785,0.000033375272,0.000029722825],"domain_scores_gemma":[0.99978536,0.000049112667,0.000062582556,0.000012228072,0.000041236577,0.000049490405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044808083,0.00026758152,0.0004032512,0.00067073264,0.0002659388,0.001280299,0.00035335368,0.00067952974,0.0015906639],"category_scores_gemma":[0.0006041071,0.0002411047,0.00030917407,0.0005721317,0.0005911162,0.0018616547,0.0006940756,0.0013724582,0.0003270803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012319678,0.00022734975,0.058926024,0.0033577643,0.0002943407,0.0011787559,0.0013282533,0.010511306,0.38704604,0.04729298,0.026640398,0.4619649],"study_design_scores_gemma":[0.00016060681,0.00117354,0.22559723,0.0017814662,0.00048961124,0.0037625139,0.0040872656,0.08822561,0.119877554,0.09182244,0.46280402,0.00021820953],"about_ca_topic_score_codex":0.001285603,"about_ca_topic_score_gemma":0.0016711194,"teacher_disagreement_score":0.0015906639,"about_ca_system_score_codex":0.0009120326,"about_ca_system_score_gemma":0.0005514049,"threshold_uncertainty_score":0.006617248},"labels":[],"label_agreement":null},{"id":"W4411096079","doi":"10.20517/cdr.2024.208","title":"Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Fibroblast growth factor receptor; Fibroblast growth factor receptor 1; Cancer research; Pediatric cancer; Neuroblastoma; Fibroblast growth factor receptor 4; Cell growth; Cancer; Fibroblast growth factor; Medicine; MAPK/ERK pathway; Receptor; Signal transduction; Biology; Cell culture; Internal medicine; Cell biology; Genetics","score_opus":0.010096935771909017,"score_gpt":0.2835060792571126,"score_spread":0.27340914348520357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411096079","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.906711,0.08621143,0.0029507673,0.00040824153,0.000018195195,0.000070929695,0.00091414957,0.00008044942,0.0026349009],"genre_scores_gemma":[0.97579485,0.020061085,0.0028554592,0.000059408874,0.00001823065,0.000029995124,0.00085247564,0.000009854471,0.00031866875],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996018,0.0000882036,0.000046939113,0.0000743619,0.0001420895,0.00004672892],"domain_scores_gemma":[0.99962497,0.00008013221,0.0002034031,0.000015655069,0.000044976296,0.000030830262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005888871,0.00028622875,0.00031855152,0.000565464,0.0001626238,0.00037712668,0.00023865681,0.00024624058,0.0008470849],"category_scores_gemma":[0.0006704297,0.000081330414,0.00026469197,0.00073160336,0.00017523371,0.00024241027,0.00022028813,0.00032127294,0.00015478166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027827166,0.00023959766,0.49468073,0.0016855125,0.00040352042,0.004808012,0.00029716184,0.0036727448,0.14578244,0.0012842859,0.0018062649,0.34255698],"study_design_scores_gemma":[0.0001275462,0.0033009204,0.8006141,0.00029155036,0.0005721744,0.052266944,0.00039523354,0.0030864947,0.09479849,0.000724382,0.043789614,0.000032627282],"about_ca_topic_score_codex":0.0013548867,"about_ca_topic_score_gemma":0.0014166334,"teacher_disagreement_score":0.0013548867,"about_ca_system_score_codex":0.0006852627,"about_ca_system_score_gemma":0.0006841844,"threshold_uncertainty_score":0.0049719214},"labels":[],"label_agreement":null}]}